A BILL 
To amend title XVIII of the Social Security Act to ensure 
Medicare-only PACE program enrollees have a choice 
of prescription drug plans under Medicare part D. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘PACE Part D Choice 
4
Act of 2021’’. 
5
16:23 Aug 11, 2021
H4941
2 
•HR 4941 IH
SEC. 2. ENSURING MEDICARE-ONLY PACE PROGRAM EN-
1
ROLLEES HAVE A CHOICE OF PRESCRIPTION 
2
DRUG PLANS UNDER MEDICARE PART D. 
3
Section 1860D–21(f) of the Social Security Act (42 
4
U.S.C. 1395w–131(f)) is amended— 
5
(1) in paragraph (1), by striking ‘‘and (3)’’ and 
6
inserting ‘‘(3), and (4)’’; and 
7
(2) by adding at the end the following new 
8
paragraph: 
9
‘‘(4) ENSURING
CHOICE
OF
PRESCRIPTION 
10
DRUG PLANS.— 
11
‘‘(A) IN GENERAL.—For plan years begin-
12
ning on or after January 1, 2023, subject to 
13
the succeeding provisions of this paragraph, an 
14
applicable PACE program enrollee may elect to 
15
enroll in a qualified standalone prescription 
16
drug plan, in accordance with rules established 
17
by the Secretary pursuant to this paragraph, 
18
while enrolled under a PACE program. 
19
‘‘(B) DEFINITION
OF
APPLICABLE
PACE 
20
PROGRAM ENROLLEE; QUALIFIED STANDALONE 
21
PRESCRIPTION DRUG PLAN.—In this paragraph: 
22
‘‘(i) APPLICABLE PACE PROGRAM EN-
23
ROLLEE.—The term ‘applicable PACE pro-
24
gram enrollee’ means a part D eligible in-
25
dividual who— 
26
16:23 Aug 11, 2021
H4941
3 
•HR 4941 IH
‘‘(I) is not entitled to medical as-
1
sistance under title XIX; and 
2
‘‘(II) is enrolled under a PACE 
3
program offered by a PACE provider. 
4
‘‘(ii) QUALIFIED
STANDALONE
PRE-
5
SCRIPTION DRUG PLAN.—The term ‘quali-
6
fied standalone prescription drug plan’ 
7
means, with respect to an applicable PACE 
8
program enrollee, a prescription drug 
9
plan— 
10
‘‘(I) that is not an MA–PD plan; 
11
‘‘(II) that is not operated by the 
12
PACE program under which the indi-
13
vidual is enrolled; and 
14
‘‘(III) for which the Secretary de-
15
termines, with respect to the applica-
16
ble PACE program enrollees enrolled 
17
in a PACE program offered by such 
18
PACE provider, that— 
19
‘‘(aa) the estimated bene-
20
ficiary out-of-pocket costs (as de-
21
fined in clause (iii)) for the plan 
22
year for qualified prescription 
23
drug coverage under the plan is 
24
equal to or less than the esti-
25
16:23 Aug 11, 2021
H4941
4 
•HR 4941 IH
mated out-of-pocket costs for 
1
such coverage under the prescrip-
2
tion drug plan offered by the 
3
PACE program in which the ap-
4
plicable PACE program enrollee 
5
is enrolled; and 
6
‘‘(bb) the estimated total 
7
amount of Federal subsidies for 
8
the plan year for qualified pre-
9
scription drug coverage under the 
10
plan (which may be estimated 
11
using data from the previous 
12
plan year) is equal to or less than 
13
the estimated subsidy amount for 
14
such coverage under the prescrip-
15
tion drug plan offered by the 
16
PACE program in which the ap-
17
plicable PACE program enrollee 
18
is enrolled. 
19
‘‘(iii) 
OUT-OF-POCKET
COSTS
DE-
20
FINED.—In this paragraph, the term ‘out- 
21
of-pocket costs’ includes premiums imposed 
22
under a prescription drug plan and, in the 
23
case of coverage under a qualified stand-
24
alone prescription drug plan, deductibles, 
25
16:23 Aug 11, 2021
H4941
5 
•HR 4941 IH
copayments, coinsurance, and other cost- 
1
sharing. 
2
‘‘(C) OUT-OF-POCKET COSTS.—In the case 
3
where an applicable PACE program enrollee 
4
elects to enroll in a qualified standalone pre-
5
scription drug plan pursuant to this paragraph, 
6
the individual shall be responsible for any out- 
7
of-pocket costs imposed under the plan (includ-
8
ing costs for nonformulary drugs) after the ap-
9
plication of any subsidies under section 1860D– 
10
14 for an applicable PACE program enrollee 
11
who is a subsidy eligible individual (as defined 
12
in section 1860D–14(a)(3)). 
13
‘‘(D) REQUIREMENTS
FOR
PACE
PRO-
14
GRAMS.— 
15
‘‘(i) EDUCATING
AND
HELPING
EN-
16
ROLL BENEFICIARIES INTO A PART D PLAN 
17
OPTION.—A PACE program shall be re-
18
quired to provide— 
19
‘‘(I) information to all applicable 
20
PACE program enrollees who are en-
21
rolled under the PACE program re-
22
garding the option to enroll in a quali-
23
fied standalone prescription drug plan 
24
under this paragraph; and 
25
16:23 Aug 11, 2021
H4941
6 
•HR 4941 IH
‘‘(II) upon request of an applica-
1
ble PACE program enrollee, coun-
2
seling and coordination to assist appli-
3
cable PACE program enrollees in 
4
making decisions regarding the selec-
5
tion of qualified standalone prescrip-
6
tion drug plans available to them. 
7
‘‘(ii) MONITORING DRUG UTILIZATION, 
8
ADHERENCE, AND SPEND.—A PACE pro-
9
gram shall be required to monitor drug 
10
utilization, medication adherence, and drug 
11
spending (through claims data shared pur-
12
suant to subparagraph (F) and otherwise) 
13
throughout the year with respect to any 
14
applicable PACE program enrollee who 
15
elects to enroll in a qualified standalone 
16
prescription drug plan under this para-
17
graph in order to coordinate with the PDP 
18
sponsor of such plan regarding the drug 
19
benefits offered by the plan, including 
20
upon request of an applicable PACE pro-
21
gram enrollee the filing of any grievances 
22
or appeals with the plan on behalf of the 
23
applicable PACE program enrollee. 
24
16:23 Aug 11, 2021
H4941
7 
•HR 4941 IH
‘‘(E) 
DISENROLLMENT.—An 
applicable 
1
PACE program enrollee may disenroll from the 
2
qualified standalone prescription drug plan 
3
elected by such applicable PACE program en-
4
rollee under subparagraph (A) if the enrollee 
5
changes medication during the plan year or can 
6
demonstrate an unexpected increase in out-of- 
7
pocket costs post enrollment. 
8
‘‘(F) CLAIMS SHARING.—In the case where 
9
an applicable PACE program enrollee enrolls in 
10
a qualified standalone prescription drug plan, 
11
the PACE program in which the individual is 
12
enrolled and the PDP sponsor of the qualified 
13
standalone prescription drug plan shall share 
14
claims data with each other with respect to the 
15
applicable PACE program enrollee as needed to 
16
support care management for the applicable 
17
PACE program enrollee (including for purposes 
18
of monitoring and coordination required under 
19
subparagraph (D)(ii)) and for purposes of com-
20
prehensive 
risk 
adjustment 
under 
section 
21
1894(d). Such data shall be shared without the 
22
need for any formal or informal request of the 
23
PACE program in which the individual is en-
24
rolled or the PDP sponsor of the qualified 
25
16:23 Aug 11, 2021
H4941
8 
•HR 4941 IH
standalone prescription drug plan in which the 
1
applicable PACE program enrollee is enrolled. 
2
‘‘(G) RULE OF CONSTRUCTION.—The au-
3
thority established under this paragraph for an 
4
applicable PACE program enrollee to elect to 
5
enroll in a qualified standalone prescription 
6
drug plan shall not be construed as permitting 
7
an applicable PACE program enrollee to enroll 
8
in a prescription drug plan that is not a quali-
9
fied standalone prescription drug plan. 
10
‘‘(H) RELATION TO PACE STATUTES.— 
11
‘‘(i) IN GENERAL.—The authority pro-
12
vided under this paragraph for an applica-
13
ble PACE program enrollee to elect to en-
14
roll in a qualified standalone prescription 
15
drug plan shall apply notwithstanding sub-
16
section (a)(1)(B)(1) of section 1894 and 
17
such other provisions of sections 1894 and 
18
1934 as the Secretary determines may con-
19
flict with the authority provided for under 
20
this 
paragraph, 
including 
subsections 
21
(a)(2)(B), 
(b)(1)(A)(i), 
(b)(1)(C), 
22
(f)(2)(B)(ii), and (f)(2)(B)(v) of such sec-
23
tions. 
24
16:23 Aug 11, 2021
H4941
9 
•HR 4941 IH
‘‘(ii) CLARIFICATION
ON
PAYMENT 
1
FOR PART D DRUG COVERAGE.—Insofar as 
2
an applicable PACE program enrollee is 
3
enrolled in a qualified standalone prescrip-
4
tion drug plan under this paragraph, the 
5
PACE program shall not be entitled to 
6
payment under section 1894(d) for the 
7
provision of qualified prescription drug 
8
coverage under such standalone prescrip-
9
tion drug plan with respect to such appli-
10
cable PACE program enrollee.’’. 
11
Æ 
16:23 Aug 11, 2021
H4941
